Owlet Extends Global Reach with Launch of Medically-Certified Dream Sock™ to South Africa

September 04, 2025 at 08:45 AM EDT

The wearable baby monitor trusted by millions globally expands reach to three continents, including North America, Europe, and now Africa.

Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announces the launch of medically-certified Dream Sock™ in South Africa. Distributed as a Class C Medical Device with CE Marking, this groundbreaking product enables parents to track Baby’s live vital signs and receive real-time health notifications, delivering greater peace of mind.

Designed for healthy babies between 0 and 18 months (2.5-13.6 kg), Dream Sock is a trusted tool for families worldwide to Monitor What Matters Most™. Using advanced, hospital-grade technology, Dream Sock tracks Baby’s pulse rate, oxygen level, and sleep patterns, sending live readings to the Owlet Dream App (available via iOS and Android) and the included Base Station. If Baby’s readings fall outside of preset zones, parents receive notifications so they can respond quickly.

“With the launch of Dream Sock as a pediatric medical device in South Africa, we’re taking another important step toward our vision of reaching every family with Owlet’s life-changing technology,” said Jonathan Harris, Owlet’s President. “As we expand into more countries, we’re making hospital-grade monitoring accessible to more parents than ever before, empowering them with the real-time insights they need to care for their little ones.”

While monitoring live vitals, parents also have access to Baby’s history of health readings and sleep patterns in the Owlet Dream App. The Owlet Dream App also features Predictive Sleep Technology, a tool that learns Baby’s past sleep patterns to recommend the best nap and bedtime windows, taking the guesswork out of daily routines. Available as Dream Duo™, Dream Sock pairs seamlessly with Owlet Cam^® 2, giving caregivers HD video and audio access to Baby from anywhere, plus motion and sound notifications.

Dream Sock has been recognized internationally for its precision and reliability, meeting rigorous medical device standards in multiple markets across several continents. It is comfortable for Baby, discreet under sleepwear, and effective even during gentle movement and across all skin tones.

Dream Sock is NAPPI coded, allowing eligible consumers to claim reimbursement from their medical aid when purchased through a pharmacy or healthcare provider (subject to applicable terms and conditions). Owlet products are available at Baby City, Babies R Us, Checkers Little Me, A-Z Baby, Takealot.com, and other online retailers.

About Owlet, Inc.

Owlet’s digital health infant monitoring platform is transforming the journey of parenting. The Company (NYSE: OWLT), a small-cap healthcare growth equity, offers FDA-cleared medical and consumer pediatric wearables and an integrated HD visual and audio camera that provides real-time data and insights to parents who safeguard health, optimize wellness, and ensure peaceful sleep for their children.

Since 2012, over two million parents worldwide have used Owlet’s platform, contributing to one of the largest collections of consumer infant health and sleep data. The Company continues to develop software and digital data solutions to bridge the current healthcare gap between hospital and home and bring new insights to parents and caregivers globally. Owlet believes that every child deserves to live a long, happy, and healthy life. To learn more, visit www.owletcare.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the Company’s launch of Dream Sock™ in South Africa, and the related impacts, growth prospects, expanded product offerings and international availability. In some cases, you can identify forward-looking statements by terms such as "estimate," "may," "believes," "plans," "expects," "anticipates," "intends," "goal," "potential," "upcoming," "outlook," "guidance," the negation thereof, or similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking statements are based on the Company’s expectations at the time such statements are made, speak only as of the dates they are made and are susceptible to a number of risks, uncertainties and other factors. For all such forward-looking statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the Reform Act. The Company’s actual results, performance or achievements may differ materially from any future results, performance or achievements expressed or implied by its forward-looking statements. Many important factors could affect the Company’s future results and cause those results to differ materially from those expressed in or implied by the Company’s forward-looking statements. Such factors include, but are not limited to, (i) the availability of, adoption and commercial success of Dream Sock in South Africa and other international markets, (ii) the regulatory pathway for Owlet’s products, including submissions to, actions taken by and decisions and responses from regulators, such as the FDA and similar regulators outside of the United States, as well as Owlet’s ability to obtain and maintain regulatory approval or certification for its products and other regulatory requirements and legal proceedings; (iii) Owlet’s competition and the Company’s ability to profitably grow and manage growth; (iv) the ability of Owlet to implement strategic initiatives, reduce costs, grow revenues, develop and launch new products, innovate and enhance existing products, meet customer demands and adapt to changes in consumer preferences and retail trends; (v) Owlet’s ability to acquire, defend and protect its intellectual property and satisfy regulatory requirements concerning privacy and data protection; (vi) Owlet’s ability to maintain relationships with customers, manufacturers and suppliers; (vii) impacts from compliance with applicable laws or regulations; (viii) the impact of and disruption to Owlet’s business, financial condition, operations, supply chain and logistics due to economic and other conditions beyond the Company’s control; (ix) adverse impacts from other economic, business, regulatory, competitive or other factors, such as changes in discretionary consumer spending and consumer preferences; and (x) other risks and uncertainties set forth in the Company’s other releases, public statements and filings with the U.S. Securities and Exchange Commission ("SEC"), including those identified in the "Risk Factors" section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and as any such factors may be updated from time to time in the Company’s other filings with the SEC. All such forward-looking statements attributable to the Company or any person acting on the Company’s behalf are expressly qualified in their entirety by the cautionary statements contained or referred to above. Moreover, the Company operates in an evolving environment. New risk factors and uncertainties may emerge from time to time, and factors that the Company currently deems immaterial may become material, and it is impossible for the Company to predict such events or how they may affect Owlet. Except as required by law, the Company assumes no obligation to update any forward-looking statements after the date of this press release, whether because of new information, future events or otherwise, although Owlet may do so from time to time. The Company does not endorse any projections regarding future performance that may be made by third parties.